Hari Kumar, MD
Vascular Surgery · Indianapolis, INNPI 1669651790
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,092 of the $4,863 with a category attached, or 84.1%. It is spread thinly across 19 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,349 and has fallen 70.1% since, to $404 in 2025.
Across 71 payments — averaging $68.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$996
- Silk Road Medical, Inc.$674
- Abbott$484
- Cook Medical LLC$271
- Philips North America LLC$267
- plus $1K from 13 others
What the payments were for
- Travel & lodging$77116%
- Food & beverage$4,09284%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $1,162 |
| Medtronic(2 entities) | 10 | $996 |
| Silk Road Medical, Inc. | 8 | $674 |
| Abbott | 6 | $484 |
| Cook Medical LLC | 4 | $271 |
| Philips North America LLC | 7 | $267 |
| W. L. Gore & Associates, Inc. | 2 | $203 |
| Reflow Medical Inc | 2 | $136 |
| Shockwave Medical, Inc | 1 | $135 |
| Medline Industries LP | 1 | $120 |
| Penumbra, Inc. | 2 | $106 |
| Inari Medical, Inc. | 4 | $86 |
| Terumo Medical Corporation | 2 | $64 |
| Cardiovascular Systems Inc. | 3 | $46 |
| EKOS Corporation | 2 | $32 |
| Amgen | 1 | $25 |
| Smith+Nephew | 1 | $22 |
| Pfizer | 1 | $19 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$929
- DIVERGENCE-L$570
- GENERAL VASCULAR INTERVENTION$470
- ENROUTE Transcarotid Stent$467
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$312
- Zenith Spiral-Z$190
- Diamondback Peripheral$167
- Perclose ProGlide suture mediated closure system$142
- Ellipsys$138
- Conformable TAG Thoracic Endoprosthesis$138
- Vascular Lithotripsy$135
- JETi All In One Non-Sterile Kit$122
- PluroGel Burn & Wound Dressings$120
- Hyalomatrix Wound Device$120
- EKOSONIC$118
- (6342) Intrasight Integ$118
How this compares
$4,863 in reported general payments places this provider in the 55th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 50 | $36,302 |
| XareltoRivaroxaban | 28 | $24,587 |
| ClopidogrelClopidogrel Bisulfate | 194 | $1,568 |
| Cilostazol | 66 | $1,383 |
| Mupirocin | 61 | $450 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $175 |
| Prednisone | 18 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $36,30250 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Indianapolis
- Sajjad HussainIndianapolis$109K
- Andres FajardoIndianapolis$58K
- Brandon DowningIndianapolis$33K
- Deepak GuttikondaIndianapolis$33K
- Jeffrey WeinbergerIndianapolis$20K
- Sarah StrotIndianapolis$15K
- Randy IrwinIndianapolis$14K
- Mary ZornIndianapolis$12K
- Charles KiellIndianapolis$10K
- Hanaa Dakour AridiIndianapolis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.